Atopy in children with systemic onset juvenile idiopathic arthritis (SoJIA) is associated with a worse outcome

References

• Ringold S, Beukelman T, Nigrovic PA, Kimura Y. Race, ethnicity, and disease outcomes in juvenile idiopathic arthritis: a cross-sectional analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. J Rheumatol 2013;40:936–942
   PubMed Web of Science ®Google Scholar
• Beukelman T, Patkar NM, Saag KG, et al. American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res 2011;63:465–482
   PubMed Web of Science ®Google Scholar
• Ramanan AV, Grom AA. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? Rheumatology 2005;44:1350–1353
   PubMed Web of Science ®Google Scholar
• Harris JG, Kessler EA, Verbsky JW. Update on the treatment of juvenile idiopathic arthritis. Curr Allergy Asthma Rep 2013;13:337–346
   PubMed Web of Science ®Google Scholar
• Spiegel LR, Schneider R, Lang BA, et al. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Arthritis Rheum 2000;43:2402–2409
   PubMed Web of Science ®Google Scholar
• Frosch M, Roth J. New insights in systemic juvenile idiopathic arthritis – from pathophysiology to treatment. Rheumatology 2008;47:121–125
   PubMed Web of Science ®Google Scholar
• Russo RA, Katsicas MM. Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome. J Rheumatol 2013;40:329–334
   PubMed Web of Science ®Google Scholar
• Vastert SJ, Kuis W, Grom AA. Systemic JIA: new developments in the understanding of the pathophysiology and therapy. Best Pract Res Clin Rheumatol 2009;23:655–664
   PubMed Web of Science ®Google Scholar
• Rossi-Semerano L, Kone-Paut I. Is Still's disease an autoinflammatory syndrome? J Inflamm 2012;2012:480373
   Google Scholar
• Ronchetti R, Rennerova Z, Barreto M, Villa MP. The prevalence of atopy in asthmatic children correlates strictly with the prevalence of atopy among nonasthmatic children. Int Arch Allergy Immunol 2007;142:79–85
   PubMed Web of Science ®Google Scholar
• Shah A. The pathologic and clinical intersection of atopic and autoimmune disease. Curr Allergy Asthma Rep 2012;12:520–529
   PubMed Web of Science ®Google Scholar
• Omoyinmi E, Hamaoui R, Pesenacker A, et al. Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis. Rheumatology 2012;51:1881–1886
   PubMed Web of Science ®Google Scholar
• Lin YT, Wang CT, Gershwin ME, Chiang BL. The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev 2011;10:482–489
   PubMed Web of Science ®Google Scholar
• Macaubas C, Nguyen K, Deshpande C, et al. Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states. Clin Immunol 2010;134:206–216
   PubMed Web of Science ®Google Scholar
• Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787–793
   PubMed Web of Science ®Google Scholar
• Sheikh A, Smeeth L, Hubbard R. There is no evidence of an inverse relationship between TH2-mediated atopy and TH1-mediated autoimmune disorders: lack of support for the hygiene hypothesis. J Allergy Clin Immunol 2003;111:131–135
   PubMed Web of Science ®Google Scholar
• Gazit V, Tasher D, Hanukoglu A, et al. Atopy in children and adolescents with insulin-dependent diabetes mellitus. Isr Med Assoc J 2008;10:858–861
   PubMed Web of Science ®Google Scholar
• Lindelof B, Granath F, Tengvall-Linder M, et al. Allergy and autoimmune disease: a registry-based study. Clin Exp Allergy 2009;39:110–115
   PubMed Web of Science ®Google Scholar
• Koh YI, Shim JU, Wi JO, et al. Inverse association of peripheral blood CD4(+) invariant natural killer T cells with atopy in human asthma. Hum Immunol 2010;71:186–191
   PubMed Web of Science ®Google Scholar
• Villanueva J, Lee S, Giannini EH, et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 2005;7:R30–R37
   PubMed Web of Science ®Google Scholar
• Agarwal S, Misra R, Aggarwal A. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol 2008;35:515–519
   PubMed Web of Science ®Google Scholar
• Davidson J, Cruikshank M. Outcome for juvenile idiopathic arthritis. Paediat Child Health 2009;20:73–78
   Google Scholar
• Yokota S, Imagawa T, Mori M, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 2008;371:998–1006
   PubMed Web of Science ®Google Scholar
• Singh-Grewal D, Schneider R, Bayer N, Feldman BM. Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. Arthritis Rheum 2006;54:1595–1601
   PubMedGoogle Scholar
• Raab A, Sengler C, Niewerth M, et al. Comorbidity profiles among adult patients with juvenile idiopathic arthritis: results of a biologic register. Clin Exp Rheumatol 2013;31:796–802
   PubMed Web of Science ®Google Scholar
• von Bubnoff D, Andres E, Hentges F, et al. Natural killer cells in atopic and autoimmune diseases of the skin. J Allergy Clin Immunol 2010;125:60–68
   PubMed Web of Science ®Google Scholar
• Zhou J, Tang X, Ding Y, et al. Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis. Pediatr Allergy Immunol 2013;24:691–696
   PubMed Web of Science ®Google Scholar
• Rosario C, Zandman-Goddard G, Meyron-Holtz EG, et al. The Hyperferritinemic Syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med 2013;11:185
   PubMed Web of Science ®Google Scholar
• Fall N, Barnes M, Thornton S, et al. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum 2007;56:3793–3804
   PubMed Web of Science ®Google Scholar